Biostar Pharmaceuticals has recently applied for a Nasdaq listing and could be a double or triple once it trades on the Nasdaq .
生物之星药业有限公司最近申请了纳斯达克上市，可能是两倍或三倍一旦它在纳斯达克的交易。
biostar